These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9121801)

  • 1. Do aminoglycoside otic preparations cause ototoxicity in the presence of tympanic membrane perforations?
    Wong DL; Rutka JA
    Otolaryngol Head Neck Surg; 1997 Mar; 116(3):404-10. PubMed ID: 9121801
    [No Abstract]   [Full Text] [Related]  

  • 2. Vestibular Hypofunction Secondary to Topical Use of Aminoglycosides in Ears with Perforated Tympanic Membrane.
    González-Aguado R; Veiga-Alonso A; Morales-Angulo C
    Audiol Neurootol; 2024; 29(5):425-428. PubMed ID: 38588647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ototoxicity of topical gentamicin preparations.
    Bath AP; Walsh RM; Bance ML; Rutka JA
    Laryngoscope; 1999 Jul; 109(7 Pt 1):1088-93. PubMed ID: 10401847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ototoxicity of ear drops: a clinical perspective.
    Linder TE; Zwicky S; Brändle P
    Am J Otol; 1995 Sep; 16(5):653-7. PubMed ID: 8588672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ototoxicity and topical eardrops.
    Marais J; Rutka JA
    Clin Otolaryngol Allied Sci; 1998 Aug; 23(4):360-7. PubMed ID: 9762501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ototoxicity of topical agents.
    Rohn GN; Meyerhoff WL; Wright CG
    Otolaryngol Clin North Am; 1993 Oct; 26(5):747-58. PubMed ID: 8233487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Topical ototoxicity: review over a 6-year period].
    Abelló P; Viñas JB; Vega J
    Acta Otorrinolaringol Esp; 1998; 49(5):353-6. PubMed ID: 9717322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamicin ear drops and ototoxicity: update.
    Stockwell M
    CMAJ; 2001 Jan; 164(1):93-4, 97-8. PubMed ID: 11202681
    [No Abstract]   [Full Text] [Related]  

  • 9. Aminoglycoside ear drop ototoxicity: a topical dilemma?
    Walby P; Stewart R; Kerr AG
    Clin Otolaryngol Allied Sci; 1998 Aug; 23(4):289-90. PubMed ID: 9762488
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for bacterial infection to cause sensorineural hearing loss in eosinophilic otitis media.
    Masuda M; Esu Y; Iino Y; Yoshida N
    Auris Nasus Larynx; 2021 Apr; 48(2):207-213. PubMed ID: 32883575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors for sensorineural hearing loss in patients with tubotympanic otitis, cholesteatoma, and tympanic membrane retractions.
    Jesic SD; Jotic AD; Babic BB
    Otol Neurotol; 2012 Aug; 33(6):934-40. PubMed ID: 22722145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ototoxicity from ototopical aminoglycosides.
    Hui Y; Park A; Crysdale WS; Forte V
    J Otolaryngol; 1997 Feb; 26(1):53-6. PubMed ID: 9055175
    [No Abstract]   [Full Text] [Related]  

  • 13. Avoidance of chloramphenicol drops in the presence of a tympanic membrane perforation.
    Mendis D; Grainger J
    Clin Otolaryngol; 2011 Oct; 36(5):520-1. PubMed ID: 22032460
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical aminoglycosides in the management of active mucosal chronic suppurative otitis media.
    Lancaster JL; Makura ZG; Porter G; McCormick M
    J Laryngol Otol; 1999 Jan; 113(1):10-2. PubMed ID: 10341911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auditory and Histopathological Effects of Topical Mercurochrome Treatment in Rats with Tympanic Membrane Perforation.
    Korkmaz S; Ceylan ME; Ceylan G; Dalgıç A; İnan S; Olgun L; Özüer MZ
    J Int Adv Otol; 2019 Apr; 15(1):22-27. PubMed ID: 30541727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intratympanic gentamicin in patients with Ménière's disease: analysis of our protocol].
    Martín Sanz E; Pérez Fernández N
    Acta Otorrinolaringol Esp; 2004; 55(6):270-6. PubMed ID: 15491114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathological findings in clinical gentamicin ototoxicity.
    Keene M; Hawke M; Barber HO; Farkashidy J
    Arch Otolaryngol; 1982 Feb; 108(2):65-70. PubMed ID: 6977353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral vestibulotoxicity due to systemic gentamicin therapy.
    Waterston JA; Halmagyi GM
    Acta Otolaryngol; 1998 Jul; 118(4):474-8. PubMed ID: 9726669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labyrinthine involvement and multiple perforations of the tympanic membrane in acute otitis media due to group A streptococci.
    Kanazawa T; Hagiwara H; Kitamura K
    J Laryngol Otol; 2000 Jan; 114(1):47-9. PubMed ID: 10789411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vestibular toxic effects induced by once-daily aminoglycoside therapy.
    Dhanireddy S; Liles WC; Gates GA
    Arch Otolaryngol Head Neck Surg; 2005 Jan; 131(1):46-8. PubMed ID: 15655184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.